IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 285, Issue 3 48-3, 2003, Pages

  Yang, Runkuan ^a   Han, Xiaonan ^a   Uchiyama, Takashi ^a   Watkins, Simon K ^a   Yaguchi, Arino ^a   Delude, Russell L ^a   Fink, Mitchell P ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Scaife Hall ^*  (United States)

Author keywords

Inducible nitric oxide synthase; Mesenteric lymph nodes; Mucosal permeability

Indexed keywords

CYCLOOXYGENASE 2; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; HEMORRHAGIC SHOCK; ILEUM MUCOSA; INTESTINE MUCOSA PERMEABILITY; KNOCKOUT MOUSE; LIVER CELL DAMAGE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESUSCITATION; STEADY STATE;

EID: 0042967332     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00177.2003     Document Type: Article

References (50)

1. Aarden LA, de Groot ER, Schaap OL, and Lansdorp PM. Production of hybridoma growth factor by human monocytes. Eur J Immunol 17: 1411-1416, 1987.
2. Aderka D, Le JM, and Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 143: 3517-3523, 1999.
3. Ammori BJ, Leeder PC, King RFGJ, Barclay GR, Martin IG, Larvin M, and McMahon MJ. Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. J Gastrointest Surg 3: 252-262, 1999.
4. Atreya R, Mudter J, Finotto S, Mullberg J, Jostock T, Wirtz S, Schutz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schurmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, and Neurath MF. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation evidence in crohn disease and experimental colitis in vivo. Nat Med 6: 583-588, 2000.
5. Ayala A, Perrin MM, Meldrum DR, Ertel W, and Chaudry IH. Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine 2: 170-174, 1999.
6. Baker JW, Deitch EA, Li M, Berg RD, and Specian RD. Hemorrhagic shock induces bacterial translocation from the gut. J Trauma 28: 896-906, 1988.
7. Campbell IL, Hobbs MV, Dockter J, Oldstone MB, and Allison J. Islet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice. Am J Pathol 145: 157-166, 1994.
8. Cuzzocrea S, De Sarro G, Constantino G, Ciliberto G, Mazzon E, De Sarro A, and Caputi AP. IL-6 knock-out mice exhibit resistance to splanchnic artery occlusion shock. J Leukoc Biol 66: 471-480, 1999.
9. Cuzzocrea S, De Sarro G, Constantino G, Mazzon E, Laura R, Ciriaco E, De Sarro A, and Caputi AP. Role of interleukin-6 in a non-septic shock model induced by zymosan. Eur Cytokine Netw 10: 191-203, 1999.
10. Cuzzocrea S, Mazzon E, De Sarro A, and Caputi AP. Role of free radicals and poly(ADP-riboSe)synthetase in intestinal tight junction permeability. Mol Med 6: 766-778, 2000.
11. Denker BM and Nigam SK. Molecular structure and assembly of the tight junction. Am J Physiol Renal Physiol 274: F1-F9, 1998.
12. Di Santo E, Alonzi T, Poli V, Fattori E, Toniatti C, Sironi M, Ricciardi-Castagnoli P, and Ghezzi P. Differential effects of IL-6 on systemic and central production of TNF: a study with IL-6-deficient mice. Cytokine 9: 300-306, 1997.
13. Doig CJ, Sutherland LR, Sandham JD, Fick GH, Verhoef M, and Meddings JB. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med 158: 444-451, 1998.
14. Fanning AS, Jameson BJ, Jesaitis LA, and Anderson JM. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 273: 29745-29753, 1998.
15. Faries PL, Simon RJ, Martella AT, Lee MJ, and Machiedo GW. Intestinal permeability correlates with severity of injury in trauma patients. J Trauma 44: 1031-1036, 1998.
16. Fattori E, Cappelletti M, Costa P, Sellitto C, Cantoni L, Carelli M, Faggioni R, Fantuzzi G, Ghezzi P, and Poli V. Defective inflammatory response in interleukin 6-deficient mice. J Exp Med 180: 1243-1250, 1994.
17. Fink MP. Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness. Curr Opin Crit Care 9: 143-151, 2003.
18. Foey AD, Parry SL, Williams LM, Feldmann M, Foxwell BM, and Brennan FM. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-α: role of the p38 and p42/44 mitogen-activated protein kinases. J Immunol 160: 920-928, 1998.
19. Gennari R and Alexander JW. Anti-interleukin-6 antibody treatment improves survival during gut-derived sepsis in time-dependent manner by enhancing host defense. Crit Care Med 23: 1945-1953, 1995.
20. Gennari R, Alexander JW, Pyles T, Hartmann S, and Ogle CK. Effects of antimurine interleukin-6 on bacterial translocation during gut-derived sepsis. Arch Surg 129: 1191-1197, 1994.
21. Grotz MR, Ding J, Guo W, Huang Q, and Deitch EA. Comparison of plasma cytokine levels in rats subjected to superior mesenteric artery occlusion or hemorrhagic shock. Shock 3: 362-368, 1995.
22. Han X, Fink MP, and Delude RL. Proinflammatory cytokines cause NO·-dependent and independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 19: 229-237, 2002.
23. Hierholzer C, Kalff JC, Bednarski B, Memarzadeh F, Kim YM, Billiar TR, and Tweardy DJ. Rapid and simultaneous activation of Stat3 and production of interleukin 6 in resuscitated hemorrhagic shock. Arch Orthop Trauma Surg 119: 332-336, 1999.
24. Hierholzer C, Kalff JC, Omert L, Tsukada K, Loeffert JE, Watkins SC, Billiar TR, and Tweardy DJ. Interleukin-6 production in hemorrhagic shock is accompanied by neutrophil recruitment and lung injury. Am J Physiol Lung Cell Mol Physiol 275: L611-L621, 1998.
25. Hilbert DM, Cancro MP, Scherle PA, Nordan RP, Van Snick J, Gerhard W, and Rudikoff S. T cell derived IL-6 is differentially required for antigen-specific antibody secretion by primary and secondary B cells. J Immunol 143: 4019-4024, 1989.
26. Hirase T, Kawashima S, Wong EY, Ueyama T, Rikitake Y, Tsukita S, Yokoyama M, and Staddon JM. Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and -independent mechanisms. J Biol Chem 276: 10423-10431, 2001.
27. Jirik FR, Podor TJ, Hirano T, Kishimoto T, Loskutoff DJ, Carson DA, and Lotz M. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial oells. J Immunol 142: 144-147, 1989.
28. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagle R, Bluethmann H, and Kohler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368: 339-342, 1994.
29. McGee DW, Beagley KW, Aicher WK, and McGhee JR. Transforming growth factor-β enhances interleukin-6 secretion by intestinal epithelial cells. Immunology 77: 7-12, 1992.
30. Meng ZH, Dyer K, Billiar TR, and Tweardy DJ. Distinct effects of systemic infusion of G-CSF vs. IL-6 on lung and liver inflammation and injury in hemorrhagic shock. Shock 14: 41-48, 2000.
31. Meng ZH, Dyer K, Billiar TR, and Tweardy DJ. Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock. Am J Physiol Cell Physiol 280: C343-C351, 2001.
32. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, and Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82: 4196-4200, 1997.
33. Oudemans-van Straaten HM, Jansen PG, Hoek FJ, van Deventer SJ, Sturk A, Stoutenbeek CP, Tytgat GN, Wildevuur CR, and Eysman L. Intestinal permeability, circulating endotoxin, and postoperative systemic responses in cardiac surgery patients. J Cardiothorac Vasc Anesth 10: 187-194, 1996.
34. Papanicolaou DA, Wilder RL, Manolagas SC, and Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128: 127-137, 1998.
35. Rijneveld AW, van den Dobbelsteen GP, Florquin S, Standiford TJ, Speelman P, van Alphen L, and van der Poll T. Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice. J Infect Dis 185: 123-126, 2002.
36. Rollwagen FM, Li YY, Pacheco ND, Dick EJ, and Kang YH. Microvascular effects of oral interleukin-6 on ischemia/reperfusion in the murine small intestine. Am J Pathol 156: 1177-1182, 2000.
37. Rollwagen FM, Li YY, Pacheco ND, and Nielsen TB. Systemic bacteraemia following hemorrhagic shock in mice: alleviation with oral interleukin 6. Cytokine 8: 121-129, 1996.
38. Rollwagen FM, Yu ZY, Li YY, and Pacheco ND. IL-6 rescues enterocytes from hemorrhage induced apoptosis in vivo and in vitro by a bcl-2 mediated mechanism. Clin Immunol Immunopathol 89: 205-213, 1998.
39. Russell DH, Barreto JC, Klemm K, and Miller TA. Hemorrhagic shock increases gut macromolecular permeability in the rat. Shock 4: 50-55, 1995.
40. Schmand JF, Ayala A, Morrison MH, and Chaudry IH. Effects of hydroxyethyl starch after trauma-hemorrhagic shock: restoration of macrophage integrity and prevention of increased circulating interleukin-6 levels. Crit Care Med 23: 806-814, 1995.
41. Stevenson BR. Understanding tight junction clinical physiology at the molecular level. J Clin Invest 104: 3-4, 1999.
42. Tawadrous ZS, Delude RL, and Fink MP. Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats. Shock 17: 473-477, 2002.
43. Tilg H, Trehu E, Atkins MB, Dinarello CA, and Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83: 113-118, 1994.
44. Wang Q, Fang CH, and Hasselgren PO. Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am J Physiol Regul Integr Comp Physiol 281: R1013-R1023, 2001.
45. Wang W, Chaudry IH, and Wang P. Increased gut permeability after hemorrhage is associated with upregulation of local and systemic IL-6. J Surg Res 79: 39-46, 1998.
46. Wattanasirichaigoon S, Menconi MJ, Delude RL, and Fink MP. Effect of mesenteric ischemia and reperfusion or hemorrhagic shock on intestinal mucosal permeability and ATP content in rats. Shock 12: 127-133, 1999.
47. Wattanasirichaigoon S, Menconi MJ, Delude RL, and Fink MP. Lisofylline ameliorates intestinal mucosal barrier dysfunction caused by ischemia and ischemia/reperfusion. Shock 11: 269-275, 1999.
48. Wattanasirichaigoon S, Menconi MJ, and Fink MP. Lisofylline ameliorates intestinal and hepatic injury induced by hemorrhage and resuscitation in rats. Crit Care Med 28: 1540-1549, 2000.
49. Yang R, Gallo DJ, Baust JJ, Uchiyama T, Watkins SK, Delude RL, and Fink MP. Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol 283: G212-G222, 2002.
50. Yang R, Gallo DJ, Baust JJ, Watkins SK, Delude RL, and Fink MP. Effect of hemorrhagic shock on gut barrier function and expression of stress-related genes in normal and gnotobiotic mice. Am J Physiol Regul Integr Comp Physiol 283: R1263-R1274, 2002.